Valuation: Revvity, Inc.

Capitalization 10.99B 9.43B 8.79B 8.18B 15.09B 947B 16.84B 106B 40.08B 444B 41.23B 40.38B 1,632B P/E ratio 2025 *
38x
P/E ratio 2026 * 30x
Enterprise value 12.76B 10.95B 10.2B 9.49B 17.51B 1,099B 19.55B 123B 46.52B 515B 47.87B 46.88B 1,894B EV / Sales 2025 *
4.47x
EV / Sales 2026 * 4.08x
Free-Float
99.71%
Yield 2025 *
0.3%
Yield 2026 * 0.29%
More valuation ratios * Estimated data
Dynamic Chart
1 day-2.36%
1 week-8.12%
Current month-3.58%
1 month-1.22%
3 months+1.57%
6 months-21.23%
Current year-16.44%
More quotes
1 week 92.39
Extreme 92.39
101.36
1 month 92.39
Extreme 92.39
104.12
Current year 87.7
Extreme 87.7
128.28
1 year 87.7
Extreme 87.7
129.5
3 years 79.5
Extreme 79.5
170
5 years 79.5
Extreme 79.5
203.16
10 years 39.5
Extreme 39.5
203.16
More quotes
Manager TitleAgeSince
Chief Executive Officer 60 2019-12-29
Director of Finance/CFO 36 2022-09-05
Chief Tech/Sci/R&D Officer - 2023-04-30
Director TitleAgeSince
Chairman 67 2019-12-29
Director/Board Member 72 2012-02-06
Director/Board Member 71 2016-07-26
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-2.36%-8.12%-15.12%-29.55% 10.99B
+0.48%+1.28%+24.63%+151.44% 186B
-2.41%-4.62%-23.28%-20.36% 157B
-0.97%+0.43%+37.18%+178.83% 153B
-2.43%-7.22%-22.36%-23.08% 136B
-1.03%+0.07%-15.52%-3.66% 59.9B
+0.41%-2.00%-10.86%-21.51% 44.87B
+3.75%+1.92%-21.23%-27.32% 37.96B
+0.58%+1.38%+26.51%+17.90% 37.76B
-0.37%+1.10%-6.20% - 34.78B
Average -0.22%-1.24%-2.63%+24.75% 85.8B
Weighted average by Cap. -0.41%-1.54%+2.32%+57.54%
See all sector performances

Financials

2025 *2026 *
Net sales 2.85B 2.45B 2.28B 2.12B 3.92B 246B 4.37B 27.56B 10.4B 115B 10.7B 10.48B 424B 3.03B 2.6B 2.42B 2.25B 4.15B 261B 4.64B 29.22B 11.03B 122B 11.35B 11.12B 449B
Net income 282M 242M 226M 210M 387M 24.29B 432M 2.72B 1.03B 11.39B 1.06B 1.04B 41.87B 363M 311M 290M 270M 498M 31.25B 556M 3.5B 1.32B 14.65B 1.36B 1.33B 53.86B
Net Debt 1.77B 1.52B 1.41B 1.32B 2.43B 152B 2.71B 17.08B 6.45B 71.43B 6.64B 6.5B 263B 1.36B 1.17B 1.09B 1.01B 1.87B 117B 2.09B 13.14B 4.96B 54.96B 5.11B 5B 202B
More financial data * Estimated data
Logo Revvity, Inc.
Revvity, Inc. (formerly PerkinElmer, Inc.) specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (including intragroup) break down by family of products as follows: - medical diagnosis equipment (61%); - analytical tools and instruments (39%): biological molecular research tools, thermal analysis software, chemical and environmental measurement tools, genetic screening instruments, reagents, etc. Net sales are distributed geographically as follows: the United States (46.7%), China (14.4%), the United Kingdom (4.1%) and other (34.8%).
Employees
11,000
More about the company
Date Price Change Volume
25-07-18 93.26 $ -2.43% 1,006,728
25-07-17 95.58 $ +0.72% 1,449,638
25-07-16 94.90 $ -1.04% 1,324,913
25-07-15 95.90 $ -2.61% 1,120,925
25-07-14 98.47 $ -2.99% 1,138,924

Delayed Quote Nyse, July 18, 2025 at 04:00 pm

More quotes
Trading Rating
Investor Rating
ESG MSCI
AAA
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
93.26USD
Average target price
123.83USD
Spread / Average Target
+32.78%
Consensus

Quarterly revenue - Rate of surprise